Company
RetinalGenix Technologies Inc. (RTGN)
Standardized SEC financial data for RetinalGenix Technologies Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001836295 · OTC · Surgical & Medical Instruments & Apparatus.
Return on equity
105.5%
Free cash flow
-$558K
Current ratio
0.01×
EPS (diluted)
$-0.13
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $432K | $748K | $809K | $524K | $373K | $83K |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2K | $5K | $38 | — | — | — |
| Total current assets |
Get RTGN data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RTGN/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RTGN/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"